To access this element change to forms mode OFF
Grant Award View - GA65923
Mechanisms of AML differentiation therapy response and relapse
GA ID:
GA65923
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
16-Dec-2019
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$808,880.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Ideas
Grant Activity:
Mechanisms of AML differentiation therapy response and relapse
Purpose:
Acute myeloid leukaemia (AML) is usually treated with toxic chemotherapy, but for some AML subtypes differentiation therapy can be used and is extremely effective. This project uses mouse and human models of AML differentiation therapy to understand how mature leukaemia cells are cleared from the body and how some cancer cells persist. These studies will improve our understanding of differentiation therapy response, with the overall goal of improving AML patient treatments.
GO ID:
GO Title:
Ideas Grants 2019
Internal Reference ID:
GNT1188885
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA